ReviewCancers2026

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions.

Xuyuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.